2014 News Releases

2014 | 2013 | 2012
DateTitle 
04/22/14Luminex Corporation Announces Norovirus as a Launch Menu Assay for its New Sample-to-Answer System, ARIES™
AUSTIN, Texas, April 22, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that norovirus will be the fourth assay in the launch menu for its new sample-to-answer system, ARIES™. The assay is designed to test for both GI and GII genogroups in a single, easy-to-use cassette. The previously announced items in the five assay launch menu targeted for the ARIES system also include: Flu A&B/RSV, HSV 1&2, and Clostridium difficile (C. diff). Future menu items will be ... 
Printer Friendly Version
04/07/14Luminex Corporation First Quarter Earnings Release Scheduled for April 28, 2014
AUSTIN, Texas, April 7, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter of 2014 on Monday, April 28, 2014. A press release announcing the results is scheduled for release after the close of trading. Management will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2014 on April 28, 2014, at 5:00 p.m. Eastern time. The conference call will ... 
Printer Friendly Version
03/17/14Pioneering Human Protein Atlas Project Achieves a Major Milestone
Project Leverages Luminex's xMAP® Technology for Biobank Profiling Research AUSTIN, Texas, March 17, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that xMAP® Technology is playing a key role in the biobank profiling research within the Human Protein Atlas (HPA) project.  In the latest release of the protein atlas, the HPA announced coverage of over 80% of the human protein-coding genes and RNA expression data for more than 90% of the genes. http://phot... 
Printer Friendly Version
02/03/14Luminex Corporation Reports Fourth Quarter And Full Year 2013 Results
AUSTIN, Texas, Feb. 3, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and year ended December 31, 2013.  Financial and operating highlights include the following: Consolidated fourth quarter revenue of $55.2 million, a 1 percent decline compared to the fourth quarter of 2012; full-year 2013 revenue was $213.4 million, a 5 percent increase over 2012 Fourth quarter royalty revenue of $9.3 million, a 23 percent increase over t... 
Printer Friendly Version
01/29/14Luminex Corporation To Present At 2014 Leerink Global Healthcare Conference
AUSTIN, Texas, Jan. 29, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 2014 Leerink Global Healthcare Conference to be held February 12 -13, 2014, in New York, NY. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 8:55 a.m. Eastern time on Thursday, February 13, 2014.  The presentation will be webcast live and may ... 
Printer Friendly Version
01/14/14Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
AUSTIN, Texas, Jan. 14, 2014 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the fourth quarter of 2013 on Monday, February 3, 2014. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the fourth quarter and twelve months ended Dece... 
Printer Friendly Version
01/02/14Luminex Corporation To Present At JP Morgan Healthcare Conference
AUSTIN, Texas, Jan. 2, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 32nd Annual JP Morgan Healthcare Conference to be held January 13-16, 2014, in San Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 4:30 p.m. Pacific time (7:30 p.m. Eastern time) on Wednesday, January 15, 2014.  The presentation ... 
Printer Friendly Version